CORRECTING and REPLACING PHOTO Tampax® and Always® Introduce the All-New Radiant Collection Designed Exclusively for …

Posted on by

CINCINNATI--(BUSINESS WIRE)--Please replace the photo for release dated May 7, 2012 with the accompanying corrected photo.

Together, we're thrilled to celebrate standout girls by giving those who have style and substance the chance to shine.

The release reads:

TAMPAXAND ALWAYSINTRODUCE THE ALL-NEW RADIANT COLLECTION DESIGNED EXCLUSIVELY FOR STANDOUT GIRLS

- Introducing the Latest Spring Collection Set To Shine In Stores Now -

Theres a new, stylish collection out in stores this season, designed to help girls stand out and keep their periods invisible. For the first time ever, Procter & Gambles (P&G) leading feminine protection brands Tampax and Always have come together to premiere the all-new Radiant Collection, a complete offering of premium tampons, pads, liners and wipes that meets all of a womans feminine care needs. The new Collection stands out on shelves and features designer packaging and wrappers that compliment any girls unique style, making these products must-have accessories any time of the month.

The Radiant Collection was designed with girls unique style and feminine care needs in mind, said Gaby Tartaret, Tampax Marketing, Combining a stylish new look with a full line-up of premium products women have grown to trust from Tampax and Always, the Radiant Collection stands out among competitive, feminine care brands.

This is P&G Fem Cares first cross-category product initiative and its biggest ever. The Radiant Collection includes Tampax tampons, Always Infinity pads, Always Incredibly Thin LinersTM and Always Radiant Wipes-to-GoTM that are packaged with a stylish new look. Its launch marks the first time that P&G Fem Care is using real girls in their advertising, showcasing the uniquely awesome women who inspired the Radiant Collection. The campaign will feature stylish and talented girls like a street artist, yarn bomber and a self-proclaimed balloonatic.

This seasons style trends are attention grabbing, but no girl wants to get noticed for her period. Thats why the Radiant Collection offers everything a woman needs to help make her period invisible, allowing her to choose what makes her stand out. To help find the ultimate collection of standout girls, Radiant is partnering with PopSugar the leading pulse on everything entertainment, style and living-related. PopSugar is featuring Radiant in its contest encouraging girls to share what makes them stand out their style, talents, smarts and interests.

Like Tampax, we celebrate the unique qualities of women by providing premium experiences through a collection of tailored assets and offerings, saidJodi Lipe, Executive Vice President of Marketing, Sugar Inc.Together, we're thrilled to celebrate standout girls by giving those who have style and substance the chance to shine.

Originally posted here:

CORRECTING and REPLACING PHOTO Tampax® and Always® Introduce the All-New Radiant Collection Designed Exclusively for ...

European Markets for Orthopedic Soft Tissue & Sports Medicine 2012

Posted on by

NEW YORK, May 9, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

European Markets for Orthopedic Soft Tissue & Sports Medicine 2012

http://www.reportlinker.com/p0256022/European-Markets-for-Orthopedic-Soft-Tissue--Sports-Medicine-2012.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Orthopedic

The European market for orthopedic soft tissue repair exceeded euro900 million in 2011.

The orthopedic soft tissue repair market consists of:

shoulder repair (rotator cuff and shoulder labrum repair),

Go here to see the original:

European Markets for Orthopedic Soft Tissue & Sports Medicine 2012

Laughter best medicine for recession

Posted on by

9 May 2012 Last updated at 11:14 ET By Shane Harrison BBC News

Do we need to laugh more during a recession?

It seems the people in the Republic do, with reports claiming satire there is making a comeback both in comedy clubs and on radio.

Please turn on JavaScript. Media requires JavaScript to play.

It's fairly common now for people in the Republic meeting on a Saturday afternoon to ask each other whether they had heard the latest episode of Green Tea or its replacement on RTE Radio One, The Second Republic.

Jokes are remembered and sketches laughed at; nothing is sacred.

Green Tea in recent times has parodied the Ulster rugby fans' recent visit to the city with both a reporter and the fans - Billy, Ivan and Jeffrey - embarrassed that there was a Padraig in their midst.

Times are changing and not just in Ulster rugby; humour and satire have returned to the Irish air waves.

In the pilot show for The Second Republic the host, Neil Delamere, jokes about reporters annoying Martin McGuinness during his visit to the ploughing championships saying: "Personally, I wouldn't have annoyed any Sinn Feiner when he had that much access to fertiliser."

While comedy and satire are thriving now many have wondered why there was so little of either during the Celtic Tiger bubble years.

Go here to read the rest:

Laughter best medicine for recession

Dr. Scott Schissel named chief of medicine at Faulkner Hospital

Posted on by

By Chelsea Conaboy, Globe Staff

Dr. Scott Schissel/Courtesy photo

Dr. Scott Schissel, chief of pulmonary medicine at Harvard Vanguard Medical Associates, has been named chief of medicine at Faulkner Hospital. Schissel starts in the new role June 15, replacing longtime chief Dr. Stephen Wright, who retired last year. Schissel will oversee the department of medicine and the educational mission there, advising residents and other trainees.

Schissel, also an instructor at Harvard Medical School, studied medicine at the College of Physicians and Surgeons at Columbia University and trained at Brigham and Womens Hospital. He will continue to see pulmonary patients there and at Faulkner Hospital.

More:

Dr. Scott Schissel named chief of medicine at Faulkner Hospital

Penn Medicine-Led Cardiovascular Health Screening Technology Receives Innovative Development Funding from American …

Posted on by

PHILADELPHIA The American Heart Association (AHA) announced today that they have made their first investment through the Science & Technology Accelerator Program into CytoVas, LLC. The company was founded by Jonni S. Moore, PhD, and Wade Rogers, PhD, Department of Pathology and Laboratory Medicine, and Emile R. Mohler III, MD, Department of Medicine, Cardiovascular Division, faculty members of the Perelman School of Medicine at the University of Pennsylvania, and will further develop research into a screen for a patient's vascular health profile. This new investment program was inaugurated by the AHA to bridge the gap from research to commercialization and bring potentially life-saving diagnostics and treatments to patients more rapidly.

The vascular health profile, currently being developed by CytoVas, measures major indicators of blood vessel health: the number of blood-vessel stem cells and the amount of microparticles, created through the natural cycle of cell death and renewal. More stem cells indicate that blood vessels have an enhanced ability to respond to changes in the body and regenerate in response to injury. High levels of microparticles appear toxic and are thought to contribute to hardening of the arteries and heart attack and stroke. Therefore, the balance of those two components is potentially of significant clinical use as an index of blood vessel health. Since nearly half of the people who have cardiovascular health problems aren't considered at high risk by most commonly used heart-health profiles, there's an urgent need to provide a comprehensive snapshot of blood-vessel damage and the reparative capacity of the body.

The AHA funds will be used by CytoVas for the next phase of development, a clinical study, which will determine whether the test can be used to monitor the effects of statin treatment.

If successful, this technology would first be used by pharmaceutical and biotech companies for drug development and clinical trials to identify cardiovascular side effects of new drugs and to identify patients who may respond particularly well to a new treatment. Ultimately, the test will be used to assess people without heart-disease symptoms who are being considered for cardiovascular preventive treatment, or for routine monitoring of the effectiveness of treatments for people who have cardiovascular disease.

The technology builds on methods developed by the flow cytometry and computational biology group of the Path BioResource center within the Penn Medicine Department of Pathology and Laboratory Medicine, who pioneered the new cell-based assay and a new analysis method termed cytometric fingerprinting. This method automates the task of analyzing large, complex datasets from flow cytometry of blood vessel cells, while at the same time eliminating unintended analyst bias.

With the support of the UPstart Program within the Center for Technology Transfer at the University of Pennsylvania, the Penn researchers co-founded CytoVas, as an early-stage, in-vitro diagnostics company. The team then brought aboard Pascal Yvon, PharmD, MBA, as the CEO and leader of the commercialization strategy. The UPstart Program works closely with Penn faculty and staff to commercialize intellectual property developed at Penn through the formation and development of entrepreneurial companies.

For more information, please read the American Heart Association news release.

The Perelman School of Medicine is currently ranked #2 in U.S. News & World Report's survey of research-oriented medical schools. The School is consistently among the nation's top recipients of funding from the National Institutes of Health, with $479.3 million awarded in the 2011 fiscal year.

The University of Pennsylvania Health System's patient care facilities include: The Hospital of the University of Pennsylvania -- recognized as one of the nation's top 10 hospitals by U.S. News & World Report; Penn Presbyterian Medical Center; and Pennsylvania Hospital the nation's first hospital, founded in 1751. Penn Medicine also includes additional patient care facilities and services throughout the Philadelphia region.

Penn Medicine is committed to improving lives and health through a variety of community-based programs and activities. In fiscal year 2011, Penn Medicine provided $854 million to benefit our community.

Read more:

Penn Medicine-Led Cardiovascular Health Screening Technology Receives Innovative Development Funding from American ...

Research and Markets: Skeletal Biology and Medicine I: Mechanisms Regulating Bone Mass

Posted on by

DUBLIN--(BUSINESS WIRE)--

Research and Markets (http://www.researchandmarkets.com/research/4zkdn4/skeletal_biology_a) has announced the addition of John Wiley and Sons Ltd's new book "Skeletal Biology and Medicine I: Mechanisms Regulating Bone Mass" to their offering.

The volume features current basic, clinical, and translational research on aspects of skeletal morphogenesis and remodeling in health and disease. Papers survey vital new insights into the mechanisms of bone development and restructuring, including cellular and mechanical triggers, receptors and signaling pathways. Also covered are the effects of other physiological systems and disease states, such as immune system inflammation, diabetes, infection, and cancer on musculoskeletal health. Recent findings are shaping therapeutic directions that focus on both anti-resorptive and anabolic therapies.

Basic scientists, clinical investigators, and clinicians with interests spanning endocrinology, physiology, cell biology, pathology, genetics, molecular biology, rheumatology, oncology, and other areas that relate to bone development and homeostasis will find this a valuable resource for the most recent developments in skeletal biology and medicine.

This volume presents manuscripts stemming from the 4th New York Skeletal Biology and Medicine Conference, held at Mount Sinai School of Medicine in New York City on April 27-30, 2011. The papers included in this volume include two of the topic areas presented at the conference; the other topic areas are included in Skeletal Biology and Medicine II.

Author

Mone Zaidi

For more information visit http://www.researchandmarkets.com/research/4zkdn4/skeletal_biology_a

Source: John Wiley and Sons Ltd

See more here:

Research and Markets: Skeletal Biology and Medicine I: Mechanisms Regulating Bone Mass

Happy birthday, New England Journal of Medicine!

Posted on by

By Chelsea Conaboy, Globe Staff

In 1819, French physician Ren Laennec published a description of the cacophony of sick lungs, deciphered with his new invention: the stethoscope. Some 18 months later, doctors in New England read about his discoveries, delivered across the sea and by horseback to their offices in one of the early editions of what would become the venerable New England Journal of Medicine.

Laennecs discoveries altered the practice of medicine in a way so fundamental that we see the effects each time our doctor listens to the sounds in our chest. Its among the first of many enduring changes in medicine that were documented by the journal and are being celebrated this year as the publication reaches its 200th anniversary.

Illustration from Cases of Organic Diseases of the Heart and Lungs, by John C. Warren, April 1, 1812, issue of the journal. (Photo courtesy New England Journal of Medicine.)

The journal, now operated by the Massachusetts Medical Society, is marking the occasion with a special website, a series of articles, and a symposium in June meant to highlight how far the field of medicine has come in two centuries.

This is an opportunity to take a look and see how much better off we are now than our forbearers, said Dr. Jeffrey Drazen, editor in chief.

The commemorative website includes an interactive timeline of the milestones in medicine that have appeared on the journals pages. For a selection, see this story by the Associated Press.

The manner in which the journal has reported on such advancements is a story in itself.

When Robert Koch gave a famous lecture in Berlin in 1882 identifying the bacteria that caused tuberculosis, the news was dispatched to the journal via telegraph and printed a week later, Drazen said.

Nearly a century later, when the Centers for Disease Control and Prevention put out its weekly bulletin reporting on four previously healthy homosexual men who had contracted an unknown infection -- what would become known as HIV -- the news reached editor Arnold Bud Relman by phone and the first articles on the disease appeared in the New England Journal of Medicine soon after, Drazen said.

See original here:

Happy birthday, New England Journal of Medicine!

BG Medicine Announces First Quarter 2012 Financial Results Release Date and Conference Call Information

Posted on by

WALTHAM, Mass., May 9, 2012 (GLOBE NEWSWIRE) -- BG Medicine Inc. (Nasdaq:BGMD - News) today announced that its financial results for the first quarter of fiscal year 2012 will be released before market open on Tuesday, May 15, 2012, followed the same day by a conference call and live webcast scheduled for 8:00am ET.

The conference call may be accessed by dialing (877) 845-1016 from the U.S. and Canada, or (708) 290-1155 from international locations. The conference call will also be available via the Internet at http://www.bg-medicine.com.

A replay of the call will be available approximately one hour following the end of the call through June 15, 2012. The replay may be accessed by dialing (855) 859-2056 within the U.S. and Canada or (404) 537-3406 from international locations, passcode 72912543. The call will be archived and accessible on the Web site for approximately 30 days.

Listeners are encouraged to login at least 15 minutes prior to the start of the scheduled presentation to register, download and install any necessary audio software.

About BG Medicine.

BG Medicine, Inc. (Nasdaq:BGMD - News) is a life sciences company focused on the discovery, development and commercialization of novel, biomarker-based cardiovascular diagnostics to address significant unmet medical needs, improve patient outcomes and contain healthcare costs. The Company's first commercialized product, the BGM Galectin-3TM test for use in patients with heart failure, is available in the United States and Europe. BG Medicine has also developed CardioSCORE, a blood test designed to identify individuals at high risk for near-term major cardiovascular events, such as heart attack and stroke. For additional information about BG Medicine, heart failure and galectin-3 testing, please visit http://www.bg-medicine.com and http://www.galectin-3.com.

The BG Medicine Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=10352

Read this article:

BG Medicine Announces First Quarter 2012 Financial Results Release Date and Conference Call Information

UM's Medical School Laying Off 800 Workers

Posted on by

UM Doctors Use Telemedicine to Continue Care In Iraq

For the past 10 years Jackson Memorial Hospital's Ryder Trauma Center has been the medical training site for the US Army _ training that was put to use in Iraq.

UM Gets Technology for New Heart Valves

The Zeego is one of the new cutting edge tools at the UM Hospitals new $2.5 million Hybrid Cath Lab.

The University of Miami's medical school on Tuesday started laying off up to 800 workers, NBC 6 learned.

The layoffs at the Leonard M. Miller School of Medicine will be completed by May 31, the end of UM's fiscal year. A Worker Adjustment and Retraining Notification was posted to floridajobs.org.

A UM spokeswoman told NBC 6 that no clinical staff workers who directly deal with patients are affected and that some workers will be rehired in restructured positions.

In a letter sent to employees April 24, Miller's Dean Dr. Pascal Goldschmidt announced the reductions, calling them "painful but essential."

"There are no easy choices due to decreases in government funding, health insurance changes, and the financial struggles of our valued partners at Jackson Memorial Hospital, and it is clear that part of our strengthening must involve rightsizing our organization and reducing our workforce," Goldschmidt said. "To remain focused on providing better care to our community, we are reducing administrative duplication and unfunded research so we may deploy more resources to our clinical operations."

Goldschmidt told NBC 6 that "patient care is entirely untouched."

Read more:

UM's Medical School Laying Off 800 Workers

A third monkey death reported at Harvard’s New England Primate Research Center

Posted on by

By Carolyn Y. Johnson, Globe Staff

A dehydrated squirrel monkey died at a Harvard Medical School research facility in December -- the third monkey to die at the New England Primate Research Center in 19 months -- and animals there also suffered a fracture and other injuries over the past three months, according to a federal inspection report released today.

The US Department of Agriculture cited Harvard for three serious incidents, which occurred after the medical school had responded to a series of other problems by replacing the centers leadership. Harvard could face fines or receive a warning because of the failures to comply with federal animal welfare regulations.

Harvard officials and the Agriculture Department report, posted on the agencys website, attributed the December 27 death and the non-fatal dehydration of a second monkey to employees failure to check a water dispensing system that had malfunctioned sometime after both monkeys arrived at the center Dec. 7.

Another squirrel monkeys leg was fractured in January, when it was caught under a door. And a group of rhesus macaques escaped from their pen in December, resulting in an injury to one monkeys foot.

The Agriculture Department considers all three incidents direct noncompliance issues, meaning there is a direct, adverse impact on the welfare of animals, or the high potential of such an effect. In fiscal year 2011, there were 25 direct noncompliance issues at research facilities nationwide.

Theyve had a tough stretch, and its certainly something thats gotten our attention and we look forward to them correcting the situation, said David Sacks, a USDA spokesman.

William W. Chin, executive dean for research at Harvard Medical School, acknowledged in an interview that there have been deficiencies in what weve been doing, leading to a number of incidents. These are regrettable. ... I would say theyre frankly unacceptable.

Chin discussed the new issues and broader problems at the primate center during a 45-minute interview earlier this month, on the condition that the Globe would not report his comments until the Agriculture Department posted the latest findings. It was the first time a medical school official had agreed to discuss the situation at the Southborough research center in depth.

He said problems with management systems and the implementation of basic procedures were discovered through a review launched in the summer of 2010, after the first monkey died. Those issues are being addressed, Chin said, through the change in the leadership team last September, disciplinary actions, new policies and procedures, and the formation of a six-member team that will perform continual reviews, training, and testing of staff, and conduct random audits.

Read this article:

A third monkey death reported at Harvard’s New England Primate Research Center

10 Most Expensive Public Medical Schools for In-State Students

Posted on by

The U.S. News Short List, separate from our overall rankings, is a regular series that magnifies individual data points in hopes of providing students and parents a way to find which undergraduate or graduate programs excel or have room to grow in specific areas. Be sure to explore The Short List: College and The Short List: Grad School to find data that matters to you in your college or grad school search.

For students interested in a medical school education, the investment of time and money may be steep. Students who attend some of the highest ranked--and often most expensive--programs may face costs of more than $50,000 annually.

Across the country, private medical programs may stretch a student's budget more than public school options. Among the 49 private medical schools that submitted tuition and required fees data to U.S. News for the 2011-2012 school year, the average annual cost was $45,870.

[Get advice on how to effectively pay for medical school.]

Students may find better deals on medical programs at public schools--and even more cost-friendly deals in their state of residence. Of the 64 public schools that submitted in-state tuition and fees data to U.S. News, the average annual cost was $28,812--compared to $50,556 a year for out-of-state students.

While tuition and fees in your state of residence may be more budget-friendly, some programs charge their in-state residents nearly as much as out-of-state students. Among the 10 most expensive public medical schools for in-state students, the average cost for the 2011-2012 school year was $38,745.

[Explore the 10 least expensive public medical schools for in-state residents.]

The University of Pittsburgh tops the list of most expensive public medical schools for in-state residents, with an average annual tuition and fees package of $44,207--about $15,000 more than the national average. Among the list of 10 most expensive public medical programs for in-state students, Pittsburgh is the highest-ranked institution for research (it ranked 15th overall in that category). Oregon Health and Science University, which costs in-state students $37,282 in tuition and fees, is the highest-ranked school on this list for primary care (it ranked third in the nation).

The F. Edward Hebert School of Medicine at the Uniformed Services University of the Health Sciences, a federal service postgraduate academy that charges $0 in tuition and fees in return for military service, was excluded from this list. Schools that were designated by U.S. News as Unranked also weren't considered for this report. U.S. News did not calculate a numerical ranking for Unranked programs because the program did not meet certain criteria that U.S. News requires to be numerically ranked.

[Discover which public medical programs award the most financial aid.]

View post:

10 Most Expensive Public Medical Schools for In-State Students

UM Medical School Plans to Lay Off 800 People

Posted on by

MIAMI -- University of Miami officials say the medical school is planning to lay off as many as 800 people. UM President Donna Shalala told The Miami Herald Tuesday that the move will better prepare the school for the future. Shalala says state budget cuts, reduced funds for research, cuts in compensation from insurers and cutbacks in payments by Jackson Health System have made the changes necessary. She says said some medical school employees will be let go, but may be rehired after restructuring of departments. Some will retire and others will accept severance packages. Shalala says no doctors or nurses who provide clinical care would be affected. Those laid off will be notified this month. The reduction amounts to 8 percent of the medical center's 10,000-person workforce.

Associated Press

The rest is here:

UM Medical School Plans to Lay Off 800 People

Dartmouth Medical School named for Dr. Seuss and wife

Posted on by

By Chelsea Conaboy, Globe Staff

Dartmouth College announced this morning that its medical school will be renamed the Geisel School of Medicine at Dartmouth in honor of the beloved illustrator and author Theodor Geisel, better known as Dr. Seuss, and his wife, Audrey.

Ted Geisel was a graduate of the class of 1925, and the family has given more money to the college during Geisels lifetime and since his death in 1991 than any other philanthropist, according to a Dartmouth press release.

Naming our school of medicine in honor of Audrey and Ted Geisel is a tribute to two individuals whose work continues to change the world for the better, Dartmouth President Jim Yong Kim said in the release. Ted Geisel lived out the Dartmouth ethos of thinking differently and creatively to illuminate the worlds challenges and the opportunities for understanding and surmounting them. . . Audrey and Ted Geisel have cared deeply for this institution, and we are enormously proud to announce this lasting partnership.

Geisel created such classic books as Green Eggs and Ham and The Cat in the Hat. The release includes this story about the beginnings of the Seuss legacy:

It was at Dartmouth that Ted Geisel discovered the excitement of marrying words to pictures, he said in a 1975 interview with the Dartmouth Alumni Magazine. I began to get it through my skull that words and pictures were Yin and Yang. I began thinking that words and pictures, married, might possibly produce a progeny more interesting than either parent.

As a student, he wrote for and eventually became the editor-in-chief of Dartmouths humor magazine, The Jack-O-Lantern. On April 11 of his senior year, Geisel organized a party for the The Jack-O-Lantern staff to celebrate the spectacular success that the humor magazine enjoyed during his tenure as editor. Geisel and companys revelry was not well received by the dean, and Geisel was told to resign from all extracurricular activities at Dartmouth, including the college humor magazine.

In order to continue work on The Jack-O-Lantern without the administrations knowledge, Geisel began signing his work for the first time with the pen name Seuss.

Excerpt from:

Dartmouth Medical School named for Dr. Seuss and wife

Harvard Medical School opens center for primary care, appoints director

Posted on by

By Liz Kowalczyk, Globe Staff

Using a $30 million anonymous gift, Harvard Medical School has opened a center to redesign primary care and make the field more attractive to new doctors. As one of its first projects, the center is creating a new training program for residents.

The medical school said Wednesday that it has hired Dr. Russell S. Phillips, a physician at Beth Israel Deaconess Medical Center, as director of the Harvard Medical School Center for Primary Care. Dr. Andrew L. Ellner was hired as co-director.

Phillips, 59, is a professor of medicine at Harvard Medical School and chief of the Division of General Medicine and Primary Care at Beth Israel Deaconess Medical Center, where he co-leads a task force to improve transitions in care and reduce readmissions. He is a graduate of the Massachusetts Institute of Technology and Stanford University School of Medicine.

Ellner, a graduate of Harvard College and Harvard Medical School, is an associate physician in the Division of Global Health Equity at Brigham and Womens Hospital and the assistant medical director of the Phyllis Jen Center for Primary Care.

Phillips said in an interview last week that the center has started an Academic Innovations Collaborative that will provide more than $10 million in funding over two years to nine primary care teaching practices at six Harvard teaching hospitals, and to eight affiliated community health centers.

The money will help the hospitals redesign their curriculum so that residents train as part of small primary care teams, rather than see patients in a clinic one afternoon a week, largely on their own. This change is part of the strategy to make the fields of internal medicine, family practice, and pediatrics more attractive to new doctors.

Residents dont want to do primary care because its so solitary, Phillips said.

He said that most practices also plan to hire nurse care managers to help residents coordinate care for the most complex patients. Caring for these patients by themselves often feels overwhelming, and getting help from experienced nurses will make caring for these patients more manageable for residents, and also result in better outcomes for our patients, Phillips said.

The new training program will go into effect at the start of the 2013-2014 academic year.

More:

Harvard Medical School opens center for primary care, appoints director

UM medical school to lay off up to 800

Posted on by

University of Miami Health System layoffs

University of Miami President Donna E. Shalala talks about layoffs at the University of Miami Health System, including the medical school. Shalala spoke to the Miami Herald Tuesday, May 8, 2012.

Chuck Fadely / Miami Herald Staff

More information

Up to 800 people will lose their jobs under a major restructuring at the University of Miami medical school, President Donna Shalala said Tuesday.

State budget cuts, less research money, lower compensation from insurers and cutbacks in payments by Jackson Health System made the changes necessary, Shalala said during a meeting at the Miami Herald.

Its not a great situation, Shalala said, but at the end of the day, well be a much stronger healthcare system of a much higher quality because we will be able to reinvest in healthcare delivery. ... Weve moved this institution to new heights. The world is changing beneath our feet.

Laid-off workers are being notified this month, Shalala said. A notice UM filed with the state Tuesday announced the university would cut 800 jobs by July 31, but Shalala said the final number is likely to be lower. The cutback is the largest by any employer in the state since the medical schools campus neighbor, Jackson, announced 920 layoffs in February.

The UM reduction amounts to 8 percent of the medical centers 10,000-person workforce. Shalala said no doctors or nurses who provide clinical care would be affected. The cuts announced Tuesday come after 182 temporary workers were laid off in late March.

Most of the UM layoffs are concentrated in research and administration as the university centralizes services to serve the entire enterprise. About 150 people who schedule appointments will lose their jobs in various departments as that service is centralized. About 150 in research administration and 110 researchers will also be let go, according to the letter UM filed with the state.

Follow this link:

UM medical school to lay off up to 800

Penn Liberty Wealth Advisors Expands

Posted on by

WAYNE, Pa., May 9, 2012 /PRNewswire/ --Penn Liberty Wealth Advisors, a division of Penn Liberty Bank in Wayne, PA has expanded its Wealth Advisor team. "Penn Liberty has experienced significant expansion in non-deposit wealth advisory business over the past few quarters. In order to support this growth we continue to grow the resources available to clients by adding highly qualified, knowledgeable, wealth advisors," said Patrick J. Ward, Chairman and Chief Executive Officer of Penn Liberty Bank.

Recent additions to the wealth advisory division include Shawn T. Higginbotham, Deborah Davis, and Joseph Dowling.

Shawn T. Higginbotham has joined Penn Liberty Wealth Advisors as an Investment Strategist. In his new position Mr. Higginbotham will be responsible for non-deposit investment strategies and financial planning for the Penn Liberty Wealth Advisory Group.

Mr. Higginbotham has 15 years of experience in the financial services industry focused on providing clients with wealth management and financial planning solutions. Prior to joining Penn Liberty Wealth Advisors he was employed by Morgan Stanley Dean Witter, SunTrust Private Banking and most recently Schwab Private Client Investment Advisory.

Mr. Higginbotham earned a BBA degree in Finance from Stetson University and an MBA with a concentration in investments from The University of Central Florida. Shawn holds the following industry registrations: Series 7, 9, 10, 63, 65, and 66*. Shawn also holds the Accredited Asset Management Specialist (AAMS) as well as Certified Financial Plannercertifications.

Shawn is a native Floridian, and currently resides in the Orlando, FL area with his wife C.J. and their son Zachary.

Deborah Davis has joined Penn Liberty Wealth Advisors as a Financial Advisor. She will primarily be responsible for further developing the financial resources offered to our customers in the Chester County region.

Ms. Davis has over nine years' experience in financial services and real estate industries. Prior to joining Penn Liberty Wealth Advisors, she was employed by Graystone Wealth Management in West Chester, Pennsylvania where she supported eight retail branches and five retirement communities. Deborah has her series 6, 7, 63* registrations and is a Certified Financial Plannerprofessional.

Ms. Davis is a resident of Paoli, Pennsylvania.

Joseph Dowling has joined Penn Liberty Wealth Advisors as a Financial Advisor. He will primarily be responsible for further developing the integration of wealth advisory within the company in the Montgomery County region.

Continue reading here:

Penn Liberty Wealth Advisors Expands

ATK Announces Complete Liberty System to Provide Commercial Crew Access

Posted on by

LOS ANGELES and ARLINGTON, Va., May 9, 2012 /PRNewswire/ -- ATK (ATK) announced today it has developed Liberty into a complete commercial crew transportation system, including the spacecraft, abort system, launch vehicle, and ground and mission operations, designed from inception to meet NASA's human-rating requirements with a potential for the first test flight in 2014 and Liberty crewed flight in 2015.

The company also announced Lockheed Martin (LMT) will provide support to the ATK and Astrium Liberty team as a major subcontractor on the project.

"Our goal in providing Liberty is to build the safest and most robust system that provides the shortest time to operation using tested and proven human-rated components," said Kent Rominger, vice president and program manager for Liberty. "Liberty will give the U.S. a new launch capability with a robust business case and a schedule that we expect will have us flying crews in just three years, ending our dependence on Russia."

"Liberty will enable a successful commercial space program and result in a globally competitive capability that America doesn't have today," said Rominger. "This program is changing the way we do business and can also result in a positive change to government programs."

Liberty's test flights are expected to begin in 2014, with a crewed mission anticipated in late 2015. The current schedule will support crewed missions for NASA and other potential customers by 2016, with a price-per-seat that is projected to be lower than the cost on the Russian Soyuz rocket.

Liberty's approach is to bring together flight-proven elements designed from inception to meet NASA's human-rating requirement, reducing development time and costs, and providing known, reliable and safe systems. The simple configuration of a solid first stage and liquid second stage lowers the likelihood of failure and enables a flight path with total abort coverage, maximizing survival for the crew in the unlikely event of an anomaly requiring an abort. In addition, the Liberty spacecraft leverages design work performed at NASA Langley Research Center on the composite crew module and launch abort system, for which ATK was a contractor.

"Because Liberty provides a safe and reliable vehicle for the crew, as well as a sustainable business for years to come, it can be a successful commercial business," said Rominger. "Liberty's business case benefits from mature, flight-proven elements that dramatically lower our up-front development costs."

Liberty has a robust and sustainable business case that will create and sustain thousands of jobs across the United States including Alabama, California, Colorado, Florida, Maryland, New York, Ohio, Texas, Utah, and Virginia. Its low remaining development cost accelerates the time to market, filling NASA's requirements, and provides a quicker return on investment to outside entities. Liberty's performance of 44,500 pounds to low-earth orbit enables the system to launch both crew and cargo and also serve non-crewed markets including ISS cargo up and down mass, commercial space station servicing, U.S. government satellite launch, and future endeavors.

"We believe that no other offering can match Liberty's safety, spacious spacecraft, customer service and performance," said Rominger. "These traits enable the Liberty business to provide the best commercial space flight experience."

The Liberty spacecraft includes a composite crew module, which ATK built at its Iuka, Miss., facility as part of a NASA risk-reduction program at Langley between 2007 and 2010. As prime contractor, ATK is responsible for the composite crew module, Max Launch Abort System (MLAS), first stage, system integration and ground and mission operations, while Astrium provides the second stage powered by the Vulcain 2 engine and Lockheed Martin provides subsystems and other support.

More:

ATK Announces Complete Liberty System to Provide Commercial Crew Access